Chemed (CHE) Operating Leases (2019 - 2026)

Chemed has reported Operating Leases for 8 years, with the latest figure at $104.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 2.32% year-over-year to $104.4 million; the trailing twelve-month figure through Mar 2026 stood at $104.4 million (up 2.32% YoY), and the FY2025 full-year result was $102.9 million, up 4.39% from the prior year.
• Operating Leases for Q1 2026 stood at $104.4 million, up from $102.9 million in the prior quarter.
• The five-year high for Operating Leases was $110.5 million in Q4 2022, with the low at $98.5 million in Q4 2024.
• Average Operating Leases over 5 years is $103.8 million, with a median of $103.4 million recorded in 2022.
• Year-over-year, Operating Leases increased 10.43% in 2022 and dropped 8.81% in 2023.
• Tracing CHE's Operating Leases over 5 years: stood at $110.5 million in 2022, then decreased by 8.81% to $100.8 million in 2023, then dropped by 2.22% to $98.5 million in 2024, then advanced by 4.39% to $102.9 million in 2025, then grew by 1.54% to $104.4 million in 2026.
• The last three Operating Leases figures came in at $104.4 million (Q1 2026), $102.9 million (Q4 2025), and $99.5 million (Q3 2025), per Business Quant data.

Peer Comparison